Susquehanna International Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-241,100
| Closed | -$42.7M | – | 11462 |
|
|
2020
Q1 | $42.7M | Sell |
241,100
-1,018,900
| -81% | -$192M | 0.01% | 721 |
|
|
2019
Q4 | $241M | Sell |
1,260,000
-353,000
| -22% | -$63.7M | 0.07% | 233 |
|
|
2019
Q3 | $271M | Sell |
1,613,000
-125,800
| -7% | -$20.5M | 0.09% | 180 |
|
|
2019
Q2 | $291M | Buy |
1,738,800
+367,500
| +27% | +$50.9M | 0.11% | 153 |
|
|
2019
Q1 | $201M | Sell |
1,371,300
-63,400
| -4% | -$9.19M | 0.08% | 201 |
|
|
2018
Q4 | $192M | Sell |
1,434,700
-580,500
| -29% | -$95.2M | 0.08% | 223 |
|
|
2018
Q3 | $384M | Buy |
2,015,200
+102,700
| +5% | +$18.9M | 0.13% | 116 |
|
|
2018
Q2 | $319M | Sell |
1,912,500
-56,000
| -3% | -$8.99M | 0.11% | 149 |
|
|
2018
Q1 | $331M | Buy |
1,968,500
+20,800
| +1% | +$3.49M | 0.12% | 131 |
|
|
2017
Q4 | $319M | Buy |
1,947,700
+335,500
| +21% | +$60.2M | 0.11% | 138 |
|
|
2017
Q3 | $330M | Sell |
1,612,200
-331,600
| -17% | -$77.1M | 0.13% | 124 |
|
|
2017
Q2 | $473M | Sell |
1,943,800
-588,100
| -23% | -$138M | 0.21% | 75 |
|
|
2017
Q1 | $605M | Buy |
2,531,900
+95,400
| +4% | +$22.2M | 0.31% | 48 |
|
|
2016
Q4 | $512M | Buy |
2,436,500
+524,700
| +27% | +$109M | 0.26% | 56 |
|
|
2016
Q3 | $440M | Sell |
1,911,800
-828,800
| -30% | -$203M | 0.21% | 68 |
|
|
2016
Q2 | $633M | Buy |
2,740,600
+1,022,400
| +60% | +$236M | 0.34% | 40 |
|
|
2016
Q1 | $461M | Sell |
1,718,200
-594,600
| -26% | -$170M | 0.25% | 62 |
|
|
2015
Q4 | $723M | Buy |
2,312,800
+818,500
| +55% | +$244M | 0.33% | 40 |
|
|
2015
Q3 | $406M | Buy |
1,494,300
+540,700
| +57% | +$166M | 0.18% | 86 |
|
|
2015
Q2 | $289M | Sell |
953,600
-927,700
| -49% | -$277M | 0.12% | 129 |
|
|
2015
Q1 | $560M | Buy |
1,881,300
+28,100
| +2% | +$8.01M | 0.25% | 47 |
|
|
2014
Q4 | $477M | Buy |
1,853,200
+632,100
| +52% | +$158M | 0.19% | 85 |
|
|
2014
Q3 | $295M | Buy |
1,221,100
+515,200
| +73% | +$115M | 0.11% | 135 |
|
|
2014
Q2 | $157M | Sell |
705,900
-230,900
| -25% | -$47.8M | 0.07% | 246 |
|
|
2014
Q1 | $193M | Buy |
936,800
+695,800
| +289% | +$138M | 0.09% | 189 |
|
|
2013
Q4 | $40.5M | Sell |
241,000
-20,000
| -8% | -$3.13M | 0.02% | 794 |
|
|
2013
Q3 | $37.6M | Sell |
261,000
-42,700
| -14% | -$5.69M | 0.02% | 752 |
|
|
2013
Q2 | $38.3M | Buy |
+303,700
| New | +$34.4M | 0.02% | 689 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Susquehanna International Group's AGN Position: Q2 2020 in Review
Susquehanna International Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 324,281 shares — an estimated $57.4M sold.
Susquehanna International Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $392M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Susquehanna International Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 324,281 Allergan plc shares in Q2 2020, an estimated $57.4M.
- Susquehanna International Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Susquehanna International Group's Allergan plc position peaked at $392M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.